BioVie
BIVI
14 hedge funds and large institutions have $7.14M invested in BioVie in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.01% less ownership
Funds ownership: 0.07% → 0.06% (-0.01%)
4% less capital invested
Capital invested by funds: $7.45M → $7.14M (-$311K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.2K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$9.97K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$8.12K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.95K |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$222K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$130K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$106K |
| 4 |
SC
Shay Capital
New York
|
-$106K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$48K |
BIVI Hedge Fund Activity: Q1 2022 in Review
14 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2022, worth a combined $7.14M — down 4.2% from $7.45M a quarter earlier.
Fund positioning in BIVI was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $22.2K. The largest seller was Kepos Capital, cutting an estimated $222K.
- 14 institutional investors held BioVie (BIVI) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $7.14M of BioVie stock for Q1 2022, down 4.2% quarter-over-quarter.
- 3 funds opened new BioVie positions in Q1 2022 and 3 closed out, a net change of 0 holders.
- The largest BioVie buyer in Q1 2022 was Geode Capital Management, an estimated $22.2K added.
- The largest BioVie seller in Q1 2022 was Kepos Capital, an estimated $222K sold.
Based on aggregated 13F filings for Q1 2022.